Original post: AwareAndPrepare.com As we have reported before, it seems the MO for many vaccine manufacturers is to get a vaccine approved for one population, and then increase the use of the vaccine to as many more patient populations as possible, regardless of whether it is safe and effective or they need it or not. […]
Spinnaker University of Northern Florida Oral Sex now major concern in causes of throat cancer 24 Mar 2011 Members of the UNF Health Promotion staff believe the rise in throat cancer can be attributed to a change in our culture’s view of oral sex. Scientists across the country are finding oral sex causes throat cancer […]
Fear or Facts? On which will you base your decision to vaccinate? While we will not try to convince anyone to get vaccinated or decline vaccination, we do encourage making an educated decision and to NEVER make a major decision out of fear. One of the most disturbing cases of fear-mongering is that which revolves around the Gardasil vaccination. The Gardasil vaccine is targeted to females ages 9-26 in hopes of”preventing” cervical cancer.
Here are some facts you need to know about HPV:
* When detected in the early stages, the HPV virus is easily treated and rarely proceeds to cancer.
* Not all women with HPV develop cervical cancer.
* HPV is just one of several potential causes of cervical cancer.
* At least 50% of sexually active men and women acquire genital HPV infection at some point in their lives — and 90% of the time the virus clears up on its own within two years, and does not lead to cancer.
The Huffington Post Dr. Jon LaPook Medical correspondent for the CBS Evening News with Katie Couric Posted: March 1, 2011 07:02 AM A study out yesterday in The Lancet by Moffitt Cancer Center researcher Anna Giuliano, Ph.D., and her colleagues finds that 50 percent of men ages 18 to 70 in Brazil, Mexico, and the […]
Online Pharma Times World News | February 23, 2011 Selina McKee Shares in French drugmaker Transgene took a small knock yesterday in Europe after Swiss drug giant Roche cut its ties with the firm’s vaccine for HPV-caused diseases. Roche terminated its 2007 agreement with Transgene under which it held exclusive global development and commercialisation rights […]